About Contrast Nephropathy Risk Calculator
Designed and programmed by: Dr. Kaveh Vejdani, MD Interactive, user-friendly App for contrast-induced nephropathy (CIN) risk estimation after percutaneous coronary intervention. Intuitive, single-view user interface with...
Designed and programmed by: Dr. Kaveh Vejdani, MD Interactive, user-friendly App for contrast-induced nephropathy (CIN) risk estimation after percutaneous coronary intervention. Intuitive, single-view user interface with quick calculation of eGFR and estimated risk of CIN and dialysis. Medical reference: "A Simple Risk Score for Prediction of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention" Mehran et al, J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9.
Jun 20, 2015 Version 2.0 Updated the UI for iOS 7 and 8
Previous Versions
Here you can find the changelog of Contrast Nephropathy Risk Calculator since it was posted on our website on 2016-10-03 17:06:02.
The latest version is 2.0 and it was updated on 2024-04-23 08:51:35. See below the changes in each version.
Contrast Nephropathy Risk Calculator version 2.0
Updated At: 2015-06-20
Changes: Jun 20, 2015 Version 2.0
Updated the UI for iOS 7 and 8
Contrast Nephropathy Risk Calculator version 2.0
Updated At: 2013-08-01
Contrast Nephropathy Risk Calculator version 2.0
Updated At: 1970-01-01
Changes: 20 июня 2015 г. Version 2.0
Updated the UI for iOS 7 and 8
Disclaimer
Official App Store Link
We do not host Contrast Nephropathy Risk Calculator on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for Contrast Nephropathy Risk Calculator is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
